One of the first case-series studies that analyzed children with COVID-19 suggest that SARS-CoV-2 should be considered for differential diagnosis in children presenting with new neurologic symptoms and splenium signal changes on MRI.
The rationale behind an ongoing study assessing the response rate, safety, and tolerability of repository corticotropin injection in patients with relapsing-remitting multiple sclerosis who have an inadequate response to high-dose steroids.

SAP Partner Banner